Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells

Fig. 2

Effects of MR16-1 on hematological parameters in the LC-06-JCK mouse model. a Hb levels, b HCT levels, c RBC counts, and d serum EPO levels were measured in mice treated for 5 weeks. Results are from 18–20 mice in each group. * P < 0.05, age-matched NTB group versus TB group (Wilcoxon test); # P < 0.05, TB group versus MR16-1 group (Wilcoxon test)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us